Target intelligence / Profile preview

Family with sequence similarity 110 member A (FAM110A)

Target
FAM110A
Molecular classification
Other (centrosome- and spindle-associated protein)
01

Overview

Family with sequence similarity 110 member A (FAM110A) is a protein localized to centrosomes and spindle poles with cell cycle–regulated expression. FAM110A is critical in mitotic progression, promoting organization of the mitotic spindle by binding and crosslinking actin (N-terminal domain) and tubulin (C-terminal domain), facilitating proper chromosome alignment, spindle assembly, and metaphase-to-anaphase transition. Its phosphorylation by Casein Kinase I is crucial for its function in mitosis[1][5][7]. It accumulates at the microtubule-organizing center during interphase and spindle poles during mitosis[1][3][7]. FAM110A is not a traditional therapeutic target (such as a receptor, enzyme, or transporter) but has emerged as a potential biomarker in cancer prognosis, particularly in breast cancer and several other malignancies, as well as being implicated in neuropsychiatric and cardiovascular conditions[1][6]. Direct drug interactions or therapeutic strategies targeting FAM110A have not been reported in the literature to date.

Other names
C20orf55BA371L19.3F110A_HUMANProtein FAM110A
02

Biological functions

Mitotic spindle organizationCell cycle regulationChromosomal alignmentSpindle pole organizationMicrotubule–actin crosslinking
03

Disease associations

Cancer (notably as a potential biomarker and in prognostic panels)Neuropsychiatric disorders (linked to depressive symptoms)Cardiovascular disease (linked to hypertension models)Other (implicated in immune infiltration in some cancers)
04

Biomarkers

Prognostic biomarker for breast cancer (DNA methylation panels in estrogen receptor–positive, node-positive breast cancer)Prognostic biomarker in multiple cancers

Beyond the preview

Go deeper on Family with sequence similarity 110 member A (FAM110A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 110 member A (FAM110A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call